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Mesenchymal stem cells (MSCs) offer great promise for cell-based therapies.
However, the mechanism of MSCs to respond to local differentiation signals in
vivo has yet to be clarified. Furthermore, MSCspossess the ability to differentiate
into multiple mesenchymal lineages. Thus, the use of MSCs as a source for in
vitro tissue engineering to repair articular cartilage defects requires the
development of methodology in the initiation, promotion and maintenance of
chondrogenesis. Chondrogenesis occurs when MSCs are grown under conditions
that include three-dimensional culture substrate, serum-free nutrient medium
and certain growth factors. MSCs were isolated and cultured from bone marrow
and peripheral blood. Mononuclear cells were separated from both types of
samples using Ficoll-Paque PLUS by centrifugation, suspended in cell culture
medium with antibiotics and were plated onto tissue culture flasks. Suspended
cells were subsequently removed after 5 days of culture, and adherent cells left
to grow. Cells were detached using trypsin-EOTA after reaching 70-90%
confluence. Cells were sub-cultured (2-5 passages) prior to further
immunophenotyping analyses and differentiation experiments. To induce
chondrogenesis, MSCs were cultured in alginate 3-dimensional scaffolds with
chondrogenic medium containing 10 nq/rnl transforming growth factor-Ba (TGF-
~3) and fibroblast growth factor-basic (BFGF). Resultant chondrogenic-MSCs
were harvested after 3-4 weeks in culture. To assess chondrogenesis, aldan-PAS
and safranin-O were used to determine cartilage matrix proteoglycan expression.
Chondrogenesis was also quantitated by sulphated glycosaminoglycan (S-GAG)
production measured by 1,9-dimethylmethylene blue (OMMB) assay. The isolated
MSCsexhibited positivity for the markers C044, C0105 and C0166, and negativity
for hematopoetic stem cell marker C034. The results showed a significant cellular
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expression of proteoglycans and glycosaminoglycans in chondrogenic-MSCs. This
study proves that successful induction of in vitro chondrogenesis is possible
from both bone marrow and peripheral blood-derived MSCswhich may provide
an alternative, viable option for stem cell therapies.
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